Omvoh
Active substance: mirikizumab
INJECTION, SOLUTION · MIRIKIZUMAB 100 mg/mL
United StatesActive
Marketing holder: Eli Lilly and Company
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- MIRIKIZUMAB · 100 mg/mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-45de-7788-abbd-5102d5b6691a,01a1208c-483f-7b30-8a8f-09e3129a9642,01a12091-067d-7d53-b48a-104d5fb747f5,01a1209c-db2e-7653-a319-9c411aef9ea8,01a1209d-69cc-7de0-ae9c-4bb2d75c507d;count=5 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0002-3116
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 0002-3116 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0002-3116 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0002-3116 · Verified 2026-10-09 · open in source